本文轉載自原廠電子報:Biomedica | www.bmgrp.com | 電子報原文
|
|
Big Endothelin-1 (Big ET-1) is a protein that is mainly produced by vascular endothelial and smooth muscle cells and cardiomyocytes. Big ET-1 has been identified as a risk factor for a poor prognosis in patients with atrial fibrillation or coronary artery disease. This current study revealed that plasma Big ET-1 is a valuable tool for risk stratification in patients with LVNC.
|
|
|
|
|
|
|
|
Big ET-1 can easily be measured using Biomedica’s ELISA:
√ Direct measurement – highly sensitive
√ CE-marked – for IVD use in the EU
√ Fully validated according to FDA/ICH/EMEA guidelines
√ Published cut-off values
|
|
|
Wang Y et al., 2017. Int J Cardiol 15;243:283-289.
Li XY et al., 2020. J Geriatr Cardiol 28;17(7):427-433.
|
|
|
|
Your Biomedica Immunoassays Team
|
|
|
|
|
